معرفی
Karin Gerritsen is an Associate Professor in Medical Research at University Medical Center Utrecht, focusing on novel kidney replacement therapies. She leads the Artificial Kidney Innovation Lab and is a key figure in the NXTGEN HIGHTECH project, which aims to develop sustainable artificial kidney technologies and vascular prostheses. Her research spans circulatory health, regenerative medicine, and stem cell applications.
- Main affiliation: University Medical Center Utrecht
- Strategic programs: Circulatory Health, Regenerative Medicine & Stem Cells
- Leadership: €37M Growth Fund project on Artificial Organs
Research Interests: Karin specializes in home dialysis and green dialysis, driving innovations like portable, wearable, and implantable artificial kidneys. Her work addresses sustainability in nephrology and aims to enhance patient autonomy through miniaturized treatment systems. She contributes to translational research via the Artificial Kidney Innovation Lab, bridging bench-to-bedside development.
Publication Trends: Her recent articles emphasize artificial kidney prototypes, uremic toxin management, and sustainable dialysis. Topics include bioengineered tubules, light-driven urea oxidation, and EU-funded initiatives like KitNewCare. These works reflect interdisciplinary collaboration between medicine, engineering, and environmental science.
Funding & Projects: Karin leads the €37M NXTGEN HIGHTECH initiative, developing production lines for artificial kidneys and vascular prostheses. Additional grants include a Dutch Kidney Foundation award for redesigning peritoneal dialysis systems and an NWO Open Technology Program for the BAKtotheFuture device. She coordinates EU projects like KitNewCare to create the world’s greenest dialysis department.
Labs & Teams: She co-founded the Artificial Kidney Innovation Lab, a multidisciplinary hub accelerating artificial kidney technologies. Her team collaborates with academia and industry across Europe, including researchers like Dimitrios Stamatialis, Rosalinde Masereeuw, and Fokko Wieringa. Key projects involve testing facilities for rapid prototyping and clinical validation.
